Similar articles

• Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS.

  Salmon D, Detruchis P, Leport C, Bouvet E, Karam D, Meyohas MC, Coulaud JP, Vildé JL. Salmon D, et al. J Infect Dis. 1991 Feb;163(2):415-6. doi: 10.1093/infdis/163.2.415. J Infect Dis. 1991. PMID: 1988528 No abstract available.
• Recurrent salmonella infection with a single strain in the acquired immunodeficiency syndrome. Confirmation by plasmid fingerprinting.

  Mayer KH, Hanson E. Mayer KH, et al. Diagn Microbiol Infect Dis. 1986 Jan;4(1):71-6. doi: 10.1016/0732-8893(86)90059-3. Diagn Microbiol Infect Dis. 1986. PMID: 3510806
• Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome.

  Smith PD, Macher AM, Bookman MA, Boccia RV, Steis RG, Gill V, Manischewitz J, Gelmann EP. Smith PD, et al. Ann Intern Med. 1985 Feb;102(2):207-9. doi: 10.7326/0003-4819-102-2-207. Ann Intern Med. 1985. PMID: 3881075 No abstract available.
• [Treatment of HIV infection with zidovudine. The good use of AZT].

  Régnier B. Régnier B. Rev Prat. 1991 Sep 1;41(19):1801-4. Rev Prat. 1991. PMID: 1925359 Review. French. No abstract available.
• [Specific treatment of neurologic manifestations of HIV infection].

  Valenciano L. Valenciano L. Arch Neurobiol (Madr). 1989;52 Suppl 1:135-40. Arch Neurobiol (Madr). 1989. PMID: 2700290 Review. Spanish.